The solution accelerates syringe selection through its comprehensive performance and regulatory data packages.

For years, Texas patients seeking relief through the Texas medical cannabis program had only a few ways to take their ...

Regeneron is planning to re-apply to the FDA with a new pre-filled syringe manufacturing filler in January 2026.

The FDA has issued another complete response letter (CRL) to Regeneron, rejecting its bid for approval of its prefilled syringe version of high-dose (HD) Eylea—again for unresolved issues at the ...